help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology, doi:10.1210/en.2006-1643
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bao, L.
Right arrow Articles by Gibori, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bao, L.
Right arrow Articles by Gibori, G.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*Protein
*UniGene
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*PROGESTERONE
Endocrinology Vol. 148, No. 5 2326-2334
Copyright © 2007 by The Endocrine Society

Decidual Prolactin Silences the Expression of Genes Detrimental to Pregnancy

Lei Bao, Christian Tessier, Anne Prigent-Tessier, Feixue Li, Oscar L. Buzzio, Eduardo A. Callegari, Nelson D. Horseman and Geula Gibori

Department of Physiology and Biophysics (L.B., C.T., A.P.-T., F.L., O.L.B., E.A.C., G.G.), University of Illinois, Chicago, Illinois 60612; and Department of Molecular and Cellular Physiology (N.D.H.), University of Cincinnati, Cincinnati, Ohio 45267

Address all correspondence and requests for reprints to: Geula Gibori, Ph.D., Department of Physiology and Biophysics (M/C 901), University of Illinois at Chicago, 835 South Wolcott Avenue, Chicago, Illinois 60612-7342. E-mail: ggibori{at}uic.edu.


   Abstract
Top
 Abstract
Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Although the main role of prolactin (PRL) in pregnant rodents is to sustain progesterone production by the corpus luteum, progesterone treatment of PRL or PRL receptor (PRL-R) null mice is unable to prevent fetal loss. We have previously shown that the rat decidua is a site of PRL production and action. In this report, we examined the hypothesis, using PRL null mice and rat decidual cell culture, that the absence of this hormone leads to the expression in the decidua of genes detrimental to pregnancy. The results show that decidual growth is normal in PRL null mice treated with PRL, progesterone, or their combination. However, the decidua of mice treated with progesterone starts expressing IL-6 and 20{alpha}-hydroxysteroid dehydrogenase (20{alpha}-HSD), two proteins absent from the decidua of wild-type mice and involved, respectively, in inflammation and progesterone catabolism. The expression of both IL-6 and 20{alpha}-HSD is prevented by PRL treatment. Our results further suggest that PRL inhibition of 20{alpha}-HSD expression is at the level of transcription and that decidual PRL (dPRL) inhibits 20{alpha}-HSD promoter activity. Inhibitors of Janus kinase 2 (Jak2) but not other kinases prevent dPRL down-regulation of the 20{alpha}-HSD promoter. Furthermore, cotransfection of the 20{alpha}-HSD promoter with expression vectors of constitutively active PRL-R, Jak2, or signal transducer and activator of transcription 5b (Stat5b) leads to substantial inhibition of promoter activity. Taken together, our investigation provides an explanation for the inability of progesterone to sustain pregnancy in PRL null mice and suggests that dPRL plays an important role in pregnancy by repressing the expression of IL-6 and 20{alpha}-HSD in the decidua. The study also demonstrates that PRL signals through the Jak2/Stat5 pathway to down-regulate 20{alpha}-HSD expression in the decidua.


   Introduction
Top
 Abstract
 Introduction
Materials and Methods
 Results
 Discussion
 References
 
ENDOMETRIAL STROMAL CELLS proliferate and differentiate to form decidual tissues during pregnancy in mammalian species. In humans, decidualization occurs in every menstrual cycle and depends primarily on levels of progesterone and estradiol (1). However, in rodents, decidualization requires, in addition to adequate levels of these hormones, an exogenous trigger, either the contact of the blastocyst during pregnancy or artificial stimulation of the uterine endometrium during pseudopregnancy (2).

Extensive investigations from our laboratory and others have shown that the decidua is able to produce hormones and cytokines. The first hormone that was shown to be secreted by the rat decidua was a prolactin (PRL)-related hormone. We had advanced the concept of decidual PRL-like luteotropin in rodents (3, 4) before PRL was shown to be produced by the human decidua (5). This luteotropic hormone was shown to bind to the PRL receptor (PRL-R) in both ovarian (6, 7, 8) and decidual cells (9) and was named decidual luteotropin (DLt). Two PRL-related genes were subsequently cloned from the rat decidua by different laboratories. The first gene cloned by the Friesen laboratory (10) was named PRL-like protein B (PLP-B). The second, cloned by the Soares group (11), was named decidual PRL-related protein (dPRP). This prompted both groups (11, 12) to suggest that these proteins could be the previously found DLt. However, further investigation failed to demonstrate that these PRL-related hormones bind to the PRL-R (13, 14), and their biological actions are still under investigation. Because DLt, identified years ago (3, 4, 6, 15), is actually the only decidual hormone that can bind the PRL-R (7, 8, 9), we reexamined this issue and succeeded at demonstrating that similar to humans, the PRL gene is expressed in the rat decidua (16) and that as previously shown for DLt, the PRL is expressed by decidual cells located in the antimesometrial site of the uterus. The cloned sequence of the decidual PRL (dPRL) is the same as pituitary PRL.

Although extensive investigations have clarified the expression and regulation of dPRL in humans (17), little is known about the role of this hormone in the maintenance of pregnancy. Our finding that the PRL gene is expressed in the decidua of rodents (16) provides an experimental animal model to study the role of this hormone.

Results obtained from PRL-R and PRL knockout (18, 19, 20) mice support an important role for dPRL in the normal progress of pregnancy. PRL and PRL-R null mice are infertile. Because the most important role of PRL in fertility is its ability to sustain progesterone production from the corpus luteum (CL) (21), these mice were treated with progesterone. Progesterone rescued implantation (18, 19, 20) and allowed for normal decidualization (22). However, extensive fetal death started from midpregnancy despite steroid treatment (18, 19, 20). This led investigators to conclude that dPRL may play a key role in the normal progress of pregnancy by acting at the level of the decidua (18, 20). Indeed, our investigations on the roles of PRL in rat decidua have revealed that PRL has potent inhibitory and stimulatory roles on some key decidual genes (23, 24, 25, 26, 27, 28).

Two proteins known to be detrimental for the normal progress of pregnancy are the cytokine IL-6 and the steroidogenic enzyme 20{alpha}-hydroxysteroid dehydrogenase (20{alpha}-HSD). We and others have shown that IL-6 normally is not expressed in the decidua (25, 29, 30). IL-6 production by decidual tissue in response to inflammation and in conjunction with other inflammatory mediators is considered to play an important role in the pathophysiology of preterm labor due to infection (31, 32). As for 20{alpha}-HSD, it is an NADPH-dependent enzyme that catabolizes progesterone, converting it to its inactive form, 20{alpha}-hydroxyprogesterone (33, 34). This enzyme plays an important role in terminating pregnancy by inactivating progesterone synthesized in the CL (34, 35, 36). 20{alpha}-HSD is not expressed in the rat CL throughout pregnancy, but its expression significantly increases just before parturition (35, 37). Similar to the ovary, 20{alpha}-HSD activity in the rat placenta was undetectable until d 20 of pregnancy and then increased dramatically on d 21 (38, 39).

Our overall goal is to examine the role of PRL in the decidua. Using the PRL null mice and primary decidual cell culture, we demonstrate in this study that dPRL is a powerful repressor of IL-6 and 20{alpha}-HSD expression in the decidua. Moreover, our results reveal that dPRL acts locally to down-regulate the transcriptional activity of the 20{alpha}-HSD gene through the long form of the PRL-R and the Janus kinase 2 (Jak2)/signal transducer and activator of transcription 5 (Stat5) signal transduction pathway.


   Materials and Methods
Top
 Abstract
 Introduction
 Materials and Methods
Results
 Discussion
 References
 
Chemicals
[{alpha}-32P]Deoxy-CTP (dCTP) was purchased from Amersham Biosciences, Inc. (Piscataway, NJ); deoxynucleotide triphosphate, ExTaq DNA polymerase, and ExTaq buffer were purchased from Takara Biomedicals (Shiga, Japan). Reverse transcriptase kit, Trizol reagent, and the nucleotides used as primers in the RT-PCR analysis were obtained from Invitrogen (Carlsbad, CA). SYBR green PCR Master Mix was obtained from Applied Biosystems (Foster City, CA). Western blotting Luminol reagent was obtained from Santa Cruz Biotechnology (Santa Cruz, CA). Tissue culture media RPMI 1640, nonessential amino acids, sodium pyruvate, trypsin-EDTA, antibiotics, and antimycotics were purchased from Mediatech (Herndon, VA). Fetal bovine serum (FBS) was purchased from HyClone Laboratories (Logan, UT). Aprotinin, leupeptin, phenylmethylsulfonyl fluoride, and wortmannin were purchased from Sigma Chemical Co. (St. Louis, MO). RIPA buffer was purchased from Boston Bioproducts (Ashland, MA). Protogel, a 30% acrylamide/bis-acrylamide mixture (37.5:1) was from National Diagnostics (Atlanta, GA). AG490, AG18, PD 98059, rapamycin, and PP2 (4-amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine) were purchased from Calbiochem (La Jolla, CA). Ovine PRL (APF 10677 C) was kindly provided by the National Institute of Diabetes and Digestive and Kidney Diseases (Bethesda, MD).

Animal models
PRL null mice were kept at 25 C with a 14-h light, 10-h dark cycle and were fed a commercial pelleted diet ad libitum. Heterozygous mutants were intercrossed to generate +/+, +/–, and –/– (null) mice, which were genotyped by PCR using tail DNA. PRL null mice or wild-type mice were mated with vasectomized males to induce pseudopregnancy, and the day on which a vaginal plug was found was designated d 1 of pseudopregnancy. Decidualization was induced on d 4 at 1000 h of pseudopregnancy by injecting sesame oil (25 µl/each uterine horn) bilaterally under ether anesthesia. Decidualization was sustained in PRL null mice by injections of progesterone (3 mg sc in sesame oil, once daily), PRL (60 µg sc in polyvinyl pyrrolidone, twice daily), or progesterone plus PRL beginning on the day of vaginal plug detection. The decidual tissues were removed from the uterus and collected on d 10. Pseudopregnant Holtzman Sprague Dawley-derived female rats were obtained from Harlan facilities (Madison, WI), and decidualization of pseudopregnant uterine endometrium was induced as described previously (25). All experimental procedures were performed in accordance with the principles of the National Institutes of Health Guide for the Care and Use of Laboratory Animals and were approved by the Institutional Animal Care and Use Committee.

Rat primary decidual cell culture
Decidual tissue, removed from the uterus of three to five pseudopregnant rats, was incubated under mild agitation in a water-jacketed cell stirrer (Wheaton Scientific, Millville, NJ) containing RPMI 1640 medium supplemented with collagenase (50 U/ml), dispase (2.4 U/ml), and deoxyribonuclease (200 U/ml) for 1 h at 37 C. At the end of the incubation, dispersed cells were filtered through a nylon mesh to remove undigested tissue and centrifuged at 1500 x g for 10 min. The cell pellet was gently resuspended in RPMI 1640 medium supplemented with 10% FBS, antibiotic-antimycotic solution (2x), nonessential amino acids (1x), sodium pyruvate (1x), and D-glucose (0.45%). Viable decidual cells, determined by the trypan blue exclusion method, were seeded in six-well plates at 1.5–2 x 106 cells per well and cultivated in a humidified atmosphere containing 5% CO2 at 37 C. After allowing the cells to attach for 3–4 h, the unattached blood cells were removed with sterile PBS. The decidual cells were then treated for 12 or 48 h with PRL, progesterone, and AG490 in RPMI 1640 phenol-free medium supplemented with 1% dextran charcoal-treated FBS. At the end of the treatment, the cells were washed twice with ice-cold PBS and frozen at –80 C until RNA extraction. In the case where transient transfections needed to be done, the cells were transfected using lipofectin reagent (Life Technologies, Inc., Rockville, MD) according to the manufacturer’s instructions. The cells were incubated with the lipofectin-reagent-DNA complexes diluted in Opti-MEM I reduced serum medium (Life Technologies) for 4 h before an equal volume of RPMI 1640 phenol red-free medium containing 2% dextran charcoal-treated FBS was added to each well with or without treatment. Medium was changed every 24 h. To harvest cells, each well was washed twice with ice-cold PBS.

RNA isolation and RT-PCR analysis
Total RNA from the decidual tissue of mice or from decidual cells was isolated using Trizol reagent according to the manufacturer’s instructions. RNA concentration was measured by photospectrometry. The RT and PCR were conducted as previously described (26). For the PCR, the conditions were such that amplification of the product was in the exponential phase, and the assay was linear with respect to the amount of input cDNA. Each PCR included ribosomal protein L19 used as an internal control. Reaction products were electrophoresed on an 8% polyacrylamide nondenaturing gel. Gels were stained with Tris-borate EDTA containing 0.5 µg/ml ethidium bromide and washed three times. The resulting gels were photographed using a UV transilluminator and a digital camera (Electrophoresis Documentation and Analysis System 120; Eastman Kodak Co., New Haven, CT). For reactions using [{alpha}-32P]dCTP, reaction products were electrophoresed on 8% polyacrylamide nondenaturing gel and were subjected to autoradiography. After autoradiography, data were analyzed using a Molecular Dynamics PhosphorImager and ImageQuant version 3 software (Molecular Dynamics, Sunnyvale, CA). For each experiment, RT-PCR were repeated at least three times.

For the mouse, the IL-6 primers used were 5'-TGG TGA CAA CCA CGG CCT TC-3' and 5'-GAG CAT TGG AAA TTG GGG TAG GA-3'. The 20{alpha}-HSD primers used were 5'-TCT TCG GTA CTT TCC TGC TGAT-3' and 5'-CTG GGG GTG AGT TGC TAAG-3' (40). The TIMP-3 primers used were 5'-CTT GTC GTG CTC CTG AGC TG-3' and 5'-CAG AGG CTT CCG TGT GAA TG-3' (41). The PRL primers used were 5'-AGC CTC TGC CAA TCT GTT CC-3' and 5'-AGG CCT GGC TAA TTA TCT TCT CA-3'. Ribosomal protein L19 primers used were 5'-AGC GCC TCC AGG CCA AGA AGG-3' and 5'-CCA GGC CGC TAT GTA CAG ACA CGA-3'.

For the rat, the 20{alpha}-HSD primers used were 5'-TAG GGC TGC CAT CTT AGT ATT CA-3' and 5'-GAA TGC CAT CTT TAT CTC AAC CA-3' as described previously (40). The L19 primers used were 5'-CTG AAG GTC AAA GGG AAT GTG-3' and 5'-GGA CAG AGT CTT GAT GAT CTC G-3'.

Real-time RT-PCR
For each real-time PCR (25 µl), cDNA was mixed with 2x SYBR Green PCR Master Mix containing primers. The mouse IL-6 primers used were 5'-CCG GAG AGG AGA CTT CAC AG-3' and 5'-TCC ACG ATT TCC CAG AGA AC-3'. The mouse 20{alpha}-HSD primers used were 5'-GGA GGC CAT GGA GAA GTG TA-3' and 5'-ATG GCA TTC TAC CTG GTT GC-3'. The mouse TIMP-3 and L19 primers used were the same as those used in RT-PCR. The PCR were carried out in duplicate or triplicate, and the samples were analyzed on an ABI 7900HT Real-Time PCR machine (Applied Biosystems). L19 was used as the internal reference. Melting curve analyses were done for both target genes and L19 to confirm the product specificity. Standard curves were generated for both the target genes and L19 to make sure that the amplification efficiencies were approximately equal.

Western blot analysis
Western blots were performed as described previously (42). Antibodies to mouse IL-6 (Sigma), TIMP-3 (Santa Cruz Biotechnology), and 20{alpha}-HSD (43) were used. Briefly 40 µg protein was separated on a 7.5% SDS-PAGE gel and transferred to a nitrocellulose membrane. Western blotting was performed by blocking nonspecific binding with 5% dry milk in Tris-buffered saline buffer containing 1% Tween 20 for 1 h at room temperature. Blots were then incubated with the primary antibody overnight at 4 C on a rocking platform. After a series of washes, blots were incubated with a secondary antibody linked to horseradish peroxidase for 1–2 h at room temperature. After extensive washing, blots were analyzed using an enhanced chemiluminescence detection system and exposed to x-ray film.

Luciferase activity measurement
For promoter analysis, we used the 2.5-kb 20{alpha}-HSD promoter cloned by our laboratory and linked to a luciferase reporter gene (20{alpha}-HSD-Luc) (44), and 0.5 µg of 20{alpha}-HSD-Luc constructs and 0.5 µg of a control ß-galactosidase expression vector (Life Technologies) were transfected into primary decidual cells. At the end of the incubation, 100 µl passive lysis buffer (Promega) was added into each well, and 20 µl cell lysate was used to measure firefly luciferase activity or ß-galactosidase activity using Promega’s Luciferase Reporter or ß-Galactosidase Assay System respectively, in a Lumat LB 9507 Luminometer (EG & G Berthold, Oak Ridge, TN). Relative light units were obtained by dividing the luciferase activity by the ß-galactosidase activity.

Statistical analysis
Data were examined by one-way ANOVA followed by the Tukey test using Prism software (GraphPad Software, Inc., San Diego, CA). For Figs. 1AGo, 2Go, and 4CGo, –/– mice were analyzed by one-way ANOVA, whereas +/+ mice were used as a normal reference. Values were considered statistically significant at P < 0.05.


Figure 1
View larger version (20K):
[in this window]
[in a new window]

  		FIG. 1. Uterus weight of wild-type and PRL null mice. A, PRL null mice were mated with vasectomized males to induce pseudopregnancy. From the day the vaginal plug was found, these mice were treated with vehicle (V), progesterone (P), PRL, or their combination. Decidualization was induced with intrauterine administration of oil. On d 10 of pseudopregnancy, uteri were collected and weighed. The –/– mice were analyzed by one-way ANOVA, whereas +/+ mice were used as a normal reference. Values are expressed as the mean ± SEM (n = 3). *, P < 0.05 vs. –/– treated with vehicle. B, dPRL expression was measured by RT-PCR as described in Materials and Methods.

 

Figure 2
View larger version (28K):
[in this window]
[in a new window]

  		FIG. 2. PRL but not progesterone prevents IL-6 expression in the mouse decidua. Decidual tissues were collected from wild-type mice and PRL null mice treated with progesterone (P), PRL, or both on d 10 of pseudopregnancy. A, TIMP-3, a decidualization marker, was measured by RT-PCR, real-time RT-PCR, and Western analysis as described in Materials and Methods. B, IL-6 expression was measured by RT-PCR, real-time RT-PCR, and Western analysis. The –/– mice were analyzed by one-way ANOVA, whereas +/+ mice were used as a normal reference. Values are expressed as the mean ± SEM (n = 3). *, P < 0.05 vs. –/– treated with progesterone.

 

Figure 4
View larger version (33K):
[in this window]
[in a new window]

  		FIG. 4. Effect of PRL and progesterone on 20{alpha}-HSD expression in the decidua. Rat primary decidual cells were isolated from pseudopregnant rats and cultured for 12 h in the presence of different doses of PRL (A) or progesterone (P) (B). Total RNA was prepared and subjected to RT-PCR analysis. C, decidual tissues were collected from wild-type mice and PRL null mice treated with progesterone, PRL, or both on d 10 of pseudopregnancy. 20{alpha}-HSD expression was measured by RT-PCR, real-time RT-PCR, and Western analysis. The –/– mice were analyzed by one-way ANOVA, whereas +/+ mice were used as a normal reference. Values are expressed as the mean ± SEM (n = 3). *, P < 0.05 vs. 0 µg/ml (cell culture) or –/– treated with progesterone (animal study).

 

   Results
Top
 Abstract
 Introduction
 Materials and Methods
 Results
Discussion
 References
 
Decidualization can be maintained with progesterone, PRL, or their combination in PRL null mice
To examine the role of PRL in the decidua and to eliminate any possible contamination by trophoblast cells, we mated PRL null mice with vasectomized males to induce pseudopregnancy. From the day the vaginal plug was found, these mice were treated with progesterone, PRL, or their combination. Control mice were PRL null mice treated with vehicle. Decidualization was induced with intrauterine administration of oil. Whereas decidualization does not occur in the uterus of PRL null mice treated with vehicle, decidualization takes place in the uterus of PRL null mice treated with PRL, progesterone, or their combination with an increase in uterine weight similar to that seen in wild-type mice used as a reference (Fig. 1AGo). Although we have previously reported that PRL expressed in the decidua is identical to pituitary PRL (16), we examined whether or not dPRL mRNA was found in the decidua of PRL null mice. As shown in Fig. 1BGo, the dPRL expressed in wild-type mice was not detectable in the decidua of null mice treated with either progesterone or PRL.

PRL but not progesterone down-regulates IL-6 expression in the mouse decidua
We and others have previously shown that IL-6 is an inflammatory cytokine not normally expressed in the decidua (25, 29, 30). Using a decidual cell line, we have previously shown that PRL can inhibit the expression of this cytokine. To examine whether PRL can indeed repress the expression of this gene in vivo, we isolated decidua from either wild-type or PRL null mice treated with PRL, progesterone, or with both hormones. As a decidualization marker (45, 46), tissue inhibitor of metalloproteinase (TIMP-3) expression was examined by RT-PCR, real-time RT-PCR, and Western analysis (Fig. 2AGo). Although PRL appears to stimulate TIMP-3 expression, it did not reach statistical difference and the level of decidual TIMP-3 expression was similar among the different groups. In sharp contrast to TIMP-3, the decidua of wild-type mice did not express IL-6 (Fig. 2BGo), and neither mRNA nor protein could be detected in this tissue. However, in PRL null mice treated with progesterone for several days, significant expression of IL-6 was detected. PRL treatment, when given either alone or with progesterone, significantly down-regulated the expression of this gene, demonstrating clearly that the lack of IL-6 expression in the decidua is due to PRL and that PRL is a physiological inhibitor of this cytokine in vivo.

Characterization of 20{alpha}-HSD expression in the rat decidua
To investigate whether 20{alpha}-HSD is expressed in the rat decidua, decidual tissue was collected on d 9–12 of pseudopregnancy. Total RNA and proteins were isolated and subjected to RT-PCR (Fig. 3AGo) and Western blot (Fig. 3BGo) analysis. The results reveal that 20{alpha}-HSD mRNA and proteins are not detectable during this period of time. However, primary decidual cells maintained in culture acquire the ability to express 20{alpha}-HSD (Fig. 3CGo), suggesting that decidual 20{alpha}-HSD expression is under inhibitory regulation in vivo.


Figure 3
View larger version (42K):
[in this window]
[in a new window]

  		FIG. 3. Correlation of developmental expression of 20{alpha}-HSD mRNA (A) and proteins (B) in the rat decidual tissue throughout pseudopregnancy with 20{alpha}-HSD mRNA expression in primary decidual cells (C). Total RNA and proteins were isolated from decidual tissue dissected from d 9–12 pseudopregnant animals. RNA isolation was also performed with primary decidual cells isolated from d 9 pseudopregnant rats that were cultured for 12 h in RPMI 1640 phenol red-free medium supplemented with 1% dextran charcoal-treated FBS. RT-PCR was performed using specific primer sets for 20{alpha}-HSD and L19 as an internal control. Western blot analysis was performed using the rat 20{alpha}-HSD polyclonal antibody produced by our laboratory (43 ). Results are from three independent experiments for each autoradiogram.

 
Effect of PRL on 20{alpha}-HSD expression in the decidua
To determine whether PRL is an inhibitory factor, we used both rat primary decidual cells and the PRL null mice. Primary decidual cells were maintained in short-term culture (12 h) because in this condition the cells remain expressing the PRL-R (47) but produce little if any PRL (16). Decidual cells were treated with increasing concentrations of either PRL or progesterone. Progesterone was used as control because in vivo, PRL stimulates progesterone production from the CL. As shown in Fig. 4AGo, treatment with PRL led to a concentration-dependent decrease in 20{alpha}-HSD expression. Progesterone had no significant inhibitory effect in culture (Fig. 4BGo). When we examined 20{alpha}-HSD expression in vivo, we found low mRNA and no protein detectable in the decidua of wild-type mice (Fig. 4CGo). Interestingly, the expression of this enzyme was substantial in PRL null mice treated with progesterone. PRL administered to PRL null mice, either alone or with progesterone prevented 20{alpha}-HSD expression.

Mechanism of PRL action on 20{alpha}-HSD promoter activity in rat decidual cells
Because the principal kinase known to be activated by PRL is Jak2 (48), we examined the effect of AG490, a classical inhibitor of this kinase, on PRL repression of 20{alpha}-HSD. As shown in Fig. 5Go, AG490 prevented PRL action, indicating that Jak2 is involved in PRL regulation of 20{alpha}-HSD expression. To determine whether PRL represses 20{alpha}-HSD expression at the level of transcription, we transfected rat decidual cells with a 2.5-kb 20{alpha}-HSD promoter, cloned in our laboratory and linked to a luciferase reporter gene (2.5-kb 20{alpha}-HSD-Luc) (44). Decidual cells were cotransfected with a ß-galactosidase construct to control for transfection efficiency and cultured for 48 h. Because decidual cells lose the PRL receptor when maintained in culture for more than 24 h (47), we also transfected a constitutively active PRL receptor (PRL-RCA) into these cells (49). The results shown in Fig. 6Go indicate that transfection of PRL-RCA induced a dramatic decrease in 20{alpha}-HSD promoter activity. Similar inhibition was observed when the cells were transfected with either a constitutively active Jak2 (Jak2-CA) (50) or a constitutively active Stat5b (Stat5b-CA) (51), indicating that PRL acts through the Jak2/Stat5 pathway to inhibit 20{alpha}-HSD promoter activity. Because rat primary decidual cells produce PRL (16) but lose the PRL-R when maintained in culture for several days, we examined whether endogenous dPRL inhibited the transcriptional activity of this promoter. The 20{alpha}-HSD-Luc promoter reporter construct was cotransfected with the long form of the PRL-R into decidual cells. Cells were allowed to recover and were treated with inhibitors for different signaling pathways. As shown in Fig. 7Go, AG18, a general tyrosine kinase inhibitor, and AG490, the more specific Jak2 inhibitor, were able to induce a 5- to 6-fold increase in 20{alpha}-HSD promoter activity. PD 98059, a MAPK inhibitor; wortmannin, a phosphatidylinositol-3-kinase inhibitor; rapamycin, an mTOR inhibitor, and PP2; a Src kinase inhibitor, had no significant effect on 20{alpha}-HSD promoter activity. These results suggest that dPRL represses 20{alpha}-HSD transcriptional activity through the Jak2/Stat5 pathway.


Figure 5
View larger version (20K):
[in this window]
[in a new window]

  		FIG. 5. Effect of AG490 on PRL-mediated inhibition of 20{alpha}-HSD expression in rat decidual cells. Rat decidual cells were cultured for 12 h with 1 µg/ml PRL in the presence of 20 µM AG490 or vehicle. 20{alpha}-HSD mRNA expression was analyzed by RT-PCR. Values are expressed as the mean ± SEM (n ≥ 3). *, P < 0.05 vs. vehicle-treated control.

 

Figure 6
View larger version (10K):
[in this window]
[in a new window]

  		FIG. 6. PRL inhibition of 20{alpha}-HSD promoter activity through the Jak2/Stat5 pathway in rat decidual cells. The 2.5-kb 20{alpha}-HSD-Luc promoter construct (0.5 µg/well) was cotransfected with PRL-RCA, Jak2-CA, or Stat5b-CA. Transient expression of the reporter gene was quantified by a standard luciferase assay and normalized against ß-galactosidase. Values are expressed as the mean ± SEM (n ≥ 3). *, P < 0.05 vs. control.

 

Figure 7
View larger version (13K):
[in this window]
[in a new window]

  		FIG. 7. Effects of several inhibitors of different signaling pathways on 20{alpha}-HSD promoter activity in rat decidual cells. Rat decidual cells were transfected with the 2.5-kb 20-HSD-Luc promoter construct (0.5 µg/well) in the presence of the long form of the PRL-R expression vector. They were then treated with AG490, a specific Jak2 inhibitor; AG18, a general tyrosine kinase inhibitor; PD 98059, a MAPK inhibitor; wortmanin, a phosphatidylinositol-3-kinase inhibitor; rapamycin, an mTOR inhibitor; and PP2, Src kinase inhibitor, for 48 h because at this time the locally produced dPRL is maximally expressed. Transient expression of the reporter gene was quantified by a standard luciferase assay and normalized against ß-galactosidase. Values are expressed as the mean ± SEM (n ≥ 3). *, P < 0.05 vs. control.

 

   Discussion
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
References
 
PRL is a single-chain protein hormone closely related to GH. More than 300 different functions have been reported so far (48, 52). In rodents, one of the major functions of PRL in pregnancy is to stimulate and maintain progesterone production from the CL (48, 52). PRL is mainly secreted by lactotrophs in the anterior pituitary. In addition, it is also secreted by several other tissues, such as lymphocytes (53) and the decidua (16). It is generally accepted that pituitary PRL functions as an endocrine hormone by entering the circulation and acting on remote target tissues, whereas PRL expressed in extrapituitary sites acts through autocrine or paracrine mechanisms to regulate local factors (17, 48).

The findings that rodent decidua produces PRL (16), expresses the PRL-R (7, 22), and responds to PRL stimulation (23, 24, 25, 26, 27, 28) together with the inability of progesterone to completely salvage pregnancy in PRL (Binart, N., S. Elizur, and G. Gibori, unpublished observations) and PRL-R null mice (18, 20) strongly suggest that dPRL may play an important role locally to allow the normal progress of pregnancy and fetal survival.

Decidualization in PRL null mice treated with either progesterone or PRL occurs normally, and decidual weight of these mice remains similar as compared with wild-type mice. This and a previous report (22) suggest that decidualization in the rodent is dependent on ovarian progesterone but not on dPRL. However, in this investigation, we present evidence that the decidua of PRL null mice treated with only progesterone expresses two factors, IL-6 and 20{alpha}-HSD, which can negatively affect pregnancy outcome and normally are not expressed in the decidua of wild-type mice. Interestingly, PRL injected either alone or with progesterone totally prevents the expression of these molecules in vivo.

We have previously shown that PRL but not progesterone inhibits the expression of the proinflammatory cytokine IL-6 in cultured decidual cells (25). This led us to examine whether dPRL is a physiological repressor of IL-6 in vivo. Results of the present investigation clearly indicate that in the absence of PRL, the decidua abundantly expresses IL-6 despite progesterone treatment. Because production of IL-6 during pregnancy may compromise fetal survival by triggering an inflammatory response, the inhibition of its expression in the decidua by PRL may be of great physiological importance. It is therefore highly possible that the premature abortion and fetal death seen in the PRL and PRL-R null mice treated with only progesterone is due, at least in part, to high expression of IL-6 in the decidua.

The second gene found to be repressed by PRL is 20{alpha}-HSD, an enzyme that catabolizes progesterone to its inactive form, 20{alpha}-hydroxyprogesterone. 20{alpha}-HSD expression in the ovary is key for the decrease in progesterone production seen just before parturition in rodents (40). However, during pregnancy, it is crucial that 20{alpha}-HSD remain silent both in the ovary (36, 40, 54, 55, 56), which is the source of progesterone production, and in the decidua, a major site of progesterone action. The high concentration of progesterone found in the CL can down-regulate luteal 20{alpha}-HSD (57). However, only a slight but not significant inhibition was observed in decidual cells treated with doses of progesterone (1 µg/ml) 10-fold higher than the one seen in the circulation of pregnant mice. Moreover, 20{alpha}-HSD is expressed at very high levels in the PRL null mice treated with progesterone, whereas no expression is seen in the decidua of the knockout mice treated with PRL. These results strongly suggest that the extensive fetal death seen in the progesterone-treated null mice from midpregnancy may be due, at least in part, to the local catabolism of progesterone by decidual 20{alpha}-HSD, reducing the levels of progesterone seen by the uterus. Therefore, inhibition of 20{alpha}-HSD by dPRL may be essential for the normal progress of pregnancy. Another important finding of the present study is that dPRL down-regulation of 20{alpha}-HSD is at the transcriptional level and involves the long form of the PRL-R and the Jak2/Stat5 signal transduction pathway.

The decidual tissue of pseudopregnancy is a great model to study gene expression in the decidua without any contamination from the embryo. However, recent work done by Bany and Cross (58) has demonstrated that the conceptus has local effects on uterine gene expression. Whether the embryo has any effect on the expression of IL-6 and 20{alpha}-HSD remains a subject for further investigation.

Taken together, our investigation provides an explanation for the inability of progesterone to sustain pregnancy in PRL null mice and indicates that dPRL plays an important role in pregnancy by repressing two genes, IL-6 and 20{alpha}-HSD, whose expression in the decidua is detrimental for the normal progress of pregnancy.


   Acknowledgments
 
We are grateful to the National Institute of Diabetes and Digestive and Kidney Diseases and the National Hormone and Pituitary Program (National Institutes of Health) for the ovine PRL, Dr. Jean Djiane for the PRL-RCA, Olli Silvennoinen for the Jak2-CA, and Dr. Toshio Kitamura for the Stat5b-CA. We thank Carlos Stocco and Julia Halperin for their input, Susan Ferguson-Gottschall and Aurora Shehu for technical support, and Jamie Le for the preparation of the manuscript.


   Footnotes
 
This work was supported by National Institutes of Health Grants HD12356, HD40093, and U54.

None of the authors has anything to disclose.

First Published Online January 25, 2007

Abbreviations: CL, Corpus luteum; dCTP, deoxy-CTP; DLt, decidual luteotropin; dPRL, decidual PRL; FBS, fetal bovine serum; 20{alpha}-HSD, 20{alpha}-hydroxysteroid dehydrogenase; Jak2, Janus kinase 2; Jak2-CA, constitutively active Jak2; PP2, 4-amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine; PRL, prolactin; PRL-R, PRL receptor; PRL-RCA, constitutively active PRL-R; Stat5, signal transducer and activator of transcription 5; Stat5b-CA, constitutively active Stat5b; TIMP, tissue inhibitor of metalloproteinase.

Received December 7, 2006.

Accepted for publication January 18, 2007.


   References
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Jabbour HN, Critchley HO 2001 Potential roles of decidual prolactin in early pregnancy. Reproduction 121:197–205[Abstract]
  2. De Feo VJ 1967 Decidualization. In: Wynn RM, ed. Cellular biology of the uterus. New York: Appleton-Century-Crofts; 191–290
  3. Gibori G, Rothchild I, Pepe GJ, Morishige WK, Lam P 1974 Luteotrophic action of decidual tissue in the rat. Endocrinology 95:1113–1118[Abstract/Free Full Text]
  4. Rothchild I, Gibori G 1975 The luteotrophic action of decidual tissue: the stimulating effect of decidualization on the serum progesterone level of pseudopregnant rats. Endocrinology 97:838–842[Abstract/Free Full Text]
  5. Riddick DH, Kusmik WF 1977 Decidua: a possible source of amniotic fluid prolactin. Am J Obstet Gynecol 127:187–190[Medline]
  6. Jayatilak PG, Glaser LA, Basuray R, Kelly PA, Gibori G 1985 Identification and partial characterization of a prolactin-like hormone produced by rat decidual tissue. Proc Natl Acad Sci USA 82:217–221[Abstract/Free Full Text]
  7. Jayatilak PG, Gibori G 1986 Ontogeny of prolactin receptors in rat decidual tissue: binding by a locally produced prolactin-like hormone. J Endocrinol 110:115–121[Abstract/Free Full Text]
  8. Jayatilak PG, Puryear TK, Herz Z, Fazleabas A, Gibori G 1989 Protein secretion by mesometrial and antimesometrial rat decidual tissue: evidence for differential gene expression. Endocrinology 125:659–666[Abstract/Free Full Text]
  9. Herz Z, Khan I, Jayatilak PG, Gibori G 1986 Evidence for the secretion of decidual luteotropin: a prolactin-like hormone produced by rat decidual cells. Endocrinology 118:2203–2209[Abstract/Free Full Text]
  10. Croze F, Kennedy TG, Schroedter IC, Friesen HG 1990 Expression of rat prolactin-like protein B in deciduoma of pseudopregnant rat and in decidua during early pregnancy. Endocrinology 127:2665–2672[Abstract/Free Full Text]
  11. Roby KF, Deb S, Gibori G, Szpirer C, Levan G, Kwok SC, Soares MJ 1993 Decidual prolactin-related protein. Identification, molecular cloning, and characterization. J Biol Chem 268:3136–3142[Abstract/Free Full Text]
  12. Gu Y, Soares MJ, Srivastava RK, Gibori G 1994 Expression of decidual prolactin-related protein in the rat decidua. Endocrinology 135:1422–1427[Abstract]
  13. Rasmussen CA, Hashizume K, Orwig KE, Xu L, Soares MJ 1996 Decidual prolactin-related protein: heterologous expression and characterization. Endocrinology 137:5558–5566[Abstract]
  14. Cohick CB, Xu L, Soares MJ 1997 Prolactin-like protein-B: heterologous expression and characterization of placental and decidual species. J Endocrinol 152:291–302[Abstract/Free Full Text]
  15. Basuray R, Gibori G 1980 Luteotropic action of decidual tissue in the pregnant rat. Biol Reprod 23:507–512[Abstract]
  16. Prigent-Tessier A, Tessier C, Hirosawa-Takamori M, Boyer C, Ferguson-Gottschall S, Gibori G 1999 Rat decidual prolactin. Identification, molecular cloning, and characterization. J Biol Chem 274:37982–37989[Abstract/Free Full Text]
  17. Ben-Jonathan N, Mershon JL, Allen DL, Steinmetz RW 1996 Extrapituitary prolactin: distribution, regulation, functions, and clinical aspects. Endocr Rev 17:639–669[Abstract/Free Full Text]
  18. Binart N, Helloco C, Ormandy CJ, Barra J, Clement-Lacroix P, Baran N, Kelly PA 2000 Rescue of preimplantatory egg development and embryo implantation in prolactin receptor-deficient mice after progesterone administration. Endocrinology 141:2691–2697[Abstract/Free Full Text]
  19. Horseman ND, Zhao W, Montecino-Rodriguez E, Tanaka M, Nakashima K, Engle SJ, Smith F, Markoff E, Dorshkind K 1997 Defective mammopoiesis, but normal hematopoiesis, in mice with a targeted disruption of the prolactin gene. EMBO J 16:6926–6935[CrossRef][Medline]
  20. Kelly PA, Binart N, Lucas B, Bouchard B, Goffin V 2001 Implications of multiple phenotypes observed in prolactin receptor knockout mice. Front Neuroendocrinol 22:140–145[CrossRef][Medline]
  21. Risk M, Gibori G 2001 Mechanisms of luteal cell regulation by prolactin. In: Horseman ND, ed. Prolactin. Norwell, MA: Kluwer Academic Publishers; 265–295
  22. Reese J, Binart N, Brown N, Ma WG, Paria BC, Das SK, Kelly PA, Dey SK 2000 Implantation and decidualization defects in prolactin receptor (PRLR)-deficient mice are mediated by ovarian but not uterine PRLR. Endocrinology 141:1872–1881[Abstract/Free Full Text]
  23. Gu Y, Jayatilak PG, Parmer TG, Gauldie J, Fey GH, Gibori G 1992 {alpha}2-Macroglobulin expression in the mesometrial decidua and its regulation by decidual luteotropin and prolactin. Endocrinology 131:1321–1328[Abstract/Free Full Text]
  24. Gibori G 1994 The decidual hormones and their role in pregnancy recognition. In: Psychoyos A, ed. Endocrinology of embryo endometrium interactions. New York: Plenum Press; 217–222
  25. Deb S, Tessier C, Prigent-Tessier A, Barkai U, Ferguson-Gottschall S, Srivastava RK, Faliszek J, Gibori G 1999 The expression of interleukin-6 (IL-6), IL-6 receptor, and gp130-kilodalton glycoprotein in the rat decidua and a decidual cell line: regulation by 17ß-estradiol and prolactin. Endocrinology 140:4442–4450[Abstract/Free Full Text]
  26. Tessier C, Deb S, Prigent-Tessier A, Ferguson-Gottschall S, Gibori GB, Shiu RP, Gibori G 2000 Estrogen receptors {alpha} and ß in rat decidua cells: cell-specific expression and differential regulation by steroid hormones and prolactin. Endocrinology 141:3842–3851[Abstract/Free Full Text]
  27. Prigent-Tessier A, Barkai U, Tessier C, Cohen H, Gibori G 2001 Characterization of a rat uterine cell line, UIII cells: prolactin (PRL) expression and endogenous regulation of PRL-dependent genes; estrogen receptor ß, {alpha}2-macroglobulin, and decidual PRL involving the Jak2 and Stat5 pathway. Endocrinology 142:1242–1250[Abstract/Free Full Text]
  28. Tessier C, Prigent-Tessier A, Ferguson-Gottschall S, Gu Y, Gibori G 2001 PRL antiapoptotic effect in the rat decidua involves the PI3K/protein kinase B-mediated inhibition of caspase-3 activity. Endocrinology 142:4086–4094[Abstract/Free Full Text]
  29. Kover K, Liang L, Andrews GK, Dey SK 1995 Differential expression and regulation of cytokine genes in the mouse uterus. Endocrinology 136:1666–1673[Abstract]
  30. Dudley DJ, Trautman MS, Araneo BA, Edwin SS, Mitchell MD 1992 Decidual cell biosynthesis of interleukin-6: regulation by inflammatory cytokines. J Clin Endocrinol Metab 74:884–889[Abstract]
  31. Kim CJ, Yoon BH, Park SS, Kim MH, Chi JG 2001 Acute funisitis of preterm but not term placentas is associated with severe fetal inflammatory response. Hum Pathol 32:623–629[CrossRef][Medline]
  32. Romero R, Avila C, Santhanam U, Sehgal PB 1990 Amniotic fluid interleukin 6 in preterm labor. Association with infection. J Clin Invest 85:1392–1400[Medline]
  33. Wiest WG, Forbes TR 1964 Failure of 20{alpha}-hydroxy-{Delta}-4-pregnen-3-one and 20-ß-hydroxy-{Delta}-4-Pregnen-3-one to maintain pregnancy in ovariectomized mice. Endocrinology 74:149–150[Medline]
  34. Talwalker PK, Krahenbuhl C, Desaulles PA 1966 Maintenance of pregnancy in spayed rats with 20{alpha}-hydroxypregn-4-ene-3-one and 20-ß-hydroxypregn-4-ene-3-one. Nature 209:86–87[CrossRef][Medline]
  35. Wiest WG 1963 In vitro metabolism of progesterone and 20{alpha}-hydroxypregn-4-en-3-one by tissues of the female rat. Endocrinology 73:310–316[Medline]
  36. Mao J, Duan RW, Zhong L, Gibori G, Azhar S 1997 Expression, purification and characterization of the rat luteal 20{alpha}-hydroxysteroid dehydrogenase. Endocrinology 138:182–190[Abstract/Free Full Text]
  37. Bast JD, Melampy RM 1972 Luteinizing hormone, prolactin and ovarian 20{alpha}-hydroxysteroid dehydrogenase levels during pregnancy and pseudopregnancy in the rat. Endocrinology 91:1499–1505[Abstract/Free Full Text]
  38. Shiota K, Seong HH, Noda K, Hattori N, Ikeda A, Ogura A, Itagaki S, Takahashi M, Ogawa T 1993 20{alpha}-Hydroxysteroid dehydrogenase activity in rat placenta. Endocr J 40:673–681[Medline]
  39. Diaz-Zagoya JC, Wiest WG, Arias F 1979 20{alpha}-Hydroxysteroid oxidoreductase activity and 20{alpha}-dihydroprogesterone concentration in human placenta before and after parturition. Am J Obstet Gynecol 133:673–676[Medline]
  40. Stocco CO, Zhong L, Sugimoto Y, Ichikawa A, Lau LF, Gibori G 2000 Prostaglandin F2{alpha}-induced expression of 20{alpha}-hydroxysteroid dehydrogenase involves the transcription factor NUR77. J Biol Chem 275:37202–37211[Abstract/Free Full Text]
  41. Harvey MB, Leco KJ, Arcellana-Panlilio MY, Zhang X, Edwards DR, Schultz GA 1995 Proteinase expression in early mouse embryos is regulated by leukaemia inhibitory factor and epidermal growth factor. Development 121:1005–1014[Abstract]
  42. Frasor J, Barkai U, Zhong L, Fazleabas AT, Gibori G 2001 PRL-induced ER{alpha} gene expression is mediated by Janus kinase 2 (Jak2) while signal transducer and activator of transcription 5b (Stat5b) phosphorylation involves Jak2 and a second tyrosine kinase. Mol Endocrinol 15:1941–1952[Abstract/Free Full Text]
  43. Albarracin CT, Gibori G 1991 Prolactin action on luteal protein expression in the corpus luteum. Endocrinology 129:1821–1830[Abstract/Free Full Text]
  44. Zhong L, Ou J, Barkai U, Mao JF, Frasor J, Gibori G 1998 Molecular cloning and characterization of the rat ovarian 20{alpha}-hydroxysteroid dehydrogenase gene. Biochem Biophys Res Commun 249:797–803[CrossRef][Medline]
  45. Reponen P, Leivo I, Sahlberg C, Apte SS, Olsen BR, Thesleff I, Tryggvason K 1995 92-kDa type IV collagenase and TIMP-3, but not 72-kDa type IV collagenase or TIMP-1 or TIMP-2, are highly expressed during mouse embryo implantation. Dev Dyn 202:388–396[Medline]
  46. Leco KJ, Edwards DR, Schultz GA 1996 Tissue inhibitor of metalloproteinases-3 is the major metalloproteinase inhibitor in the decidualizing murine uterus. Mol Reprod Dev 45:458–465[CrossRef][Medline]
  47. Gu Y, Srivastava RK, Clarke DL, Linzer DI, Gibori G 1996 The decidual prolactin receptor and its regulation by decidua-derived factors. Endocrinology 137:4878–4885[Abstract]
  48. Bole-Feysot C, Goffin V, Edery M, Binart N, Kelly PA 1998 Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice. Endocr Rev 19:225–268[Abstract/Free Full Text]
  49. Gourdou I, Gabou L, Paly J, Kermabon AY, Belair L, Djiane J 1996 Development of a constitutively active mutant form of the prolactin receptor, a member of the cytokine receptor family. Mol Endocrinol 10:45–56[Abstract/Free Full Text]
  50. Saharinen P, Takaluoma K, Silvennoinen O 2000 Regulation of the Jak2 tyrosine kinase by its pseudokinase domain. Mol Cell Biol 20:3387–3395[Abstract/Free Full Text]
  51. Onishi M, Nosaka T, Misawa K, Mui AL, Gorman D, McMahon M, Miyajima A, Kitamura T 1998 Identification and characterization of a constitutively active STAT5 mutant that promotes cell proliferation. Mol Cell Biol 18:3871–3879[Abstract/Free Full Text]
  52. Freeman ME, Kanyicska B, Lerant A, Nagy G 2000 Prolactin: structure, function, and regulation of secretion. Physiol Rev 80:1523–1631[Abstract/Free Full Text]
  53. Montgomery DW 2001 Prolactin production by immune cells. Lupus 10:665–675[Abstract/Free Full Text]
  54. Albarracin CT, Parmer TG, Duan WR, Nelson SE, Gibori G 1994 Identification of a major prolactin-regulated protein as 20{alpha}-hydroxysteroid dehydrogenase: coordinate regulation of its activity, protein content, and messenger ribonucleic acid expression. Endocrinology 134:2453–2460[Abstract/Free Full Text]
  55. Mao J, Duan WR, Albarracin CT, Parmer TG, Gibori G 1994 Isolation and characterization of a rat luteal cDNA encoding 20{alpha}-hydroxysteroid dehydrogenase. Biochem Biophys Res Commun 201:1289–1295[CrossRef][Medline]
  56. Zhong L, Parmer TG, Robertson MC, Gibori G 1997 Prolactin-mediated inhibition of 20{alpha}-hydroxysteroid dehydrogenase gene expression and the tyrosine kinase system. Biochem Biophys Res Commun 235:587–592[CrossRef][Medline]
  57. Sugino N, Telleria CM, Gibori G 1997 Progesterone inhibits 20{alpha}-hydroxysteroid dehydrogenase expression in the rat corpus luteum through the glucocorticoid receptor. Endocrinology 138:4497–4500[Abstract/Free Full Text]
  58. Bany BM, Cross JC 2006 Post-implantation mouse conceptuses produce paracrine signals that regulate the uterine endometrium undergoing decidualization. Dev Biol 294:445–456[CrossRef][Medline]



This article has been cited by other articles:


Home page
 EndocrinologyHome page
Y. S. Devi, A. Shehu, C. Stocco, J. Halperin, J. Le, A. M. Seibold, M. Lahav, N. Binart, and G. Gibori
Regulation of Transcription Factors and Repression of Sp1 by Prolactin Signaling Through the Short Isoform of Its Cognate Receptor
Endocrinology, July 1, 2009; 150(7): 3327 - 3335.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
V. J. Lynch, A. Tanzer, Y. Wang, F. C. Leung, B. Gellersen, D. Emera, and G. P. Wagner
Adaptive changes in the transcription factor HoxA-11 are essential for the evolution of pregnancy in mammals
PNAS, September 30, 2008; 105(39): 14928 - 14933.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C.-Y. Tsai, C.-K. Chou, C.-W. Yang, Y.-C. Lai, C.-C. Liang, C.-M. Chen, and T.-F. Tsai
Hurp Deficiency in Mice Leads to Female Infertility Caused by an Implantation Defect
J. Biol. Chem., September 26, 2008; 283(39): 26302 - 26306.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bao, L.
Right arrow Articles by Gibori, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bao, L.
Right arrow Articles by Gibori, G.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*Protein
*UniGene
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*PROGESTERONE

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals